Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Latest Mizuho News

See all news
The Energy Department's '$17 billion question' around nuclear energy

The Energy Department's '$17 billion question' around nuclear energy

June 29, 2026
Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

Robinhood could be first ‘hyperscaler’ of online brokerages, says Mizuho’s Dan Dolev

July 2, 2026
Why SpaceX's future depends on Starship

Why SpaceX's future depends on Starship

July 20, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue